Focus on Lipids Care

Back to articles

Statins and the High-Risk Elderly: Pravastatin Safe and Well Tolerated


Results of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) extend the health benefits of statins into the elderly patient population.


Shepherd J et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–30.

Collins R, Armitage J. High-risk elderly patients PROSPER from cholesterol-lowering therapy [editorial]. Lancet. 2002;360:1618–9.